Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer An Initial Report From the Surveillance, Epidemiology, and End Results Program

被引:127
作者
Murphy, Caitlin C. [1 ,2 ]
Gerber, David E. [1 ,2 ,3 ]
Pruitt, Sandi L. [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[2] Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
基金
美国国家卫生研究院;
关键词
UNITED-STATES; LUNG-CANCER; SURVIVORS; CARE;
D O I
10.1001/jamaoncol.2017.3605
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMPORTANCE The US cancer survivor population is rapidly growing. Cancer survivors are frequently excluded from cancer clinical trials and observational research. OBJECTIVE To examine prevalence of prior cancer among individuals newly diagnosed with cancer. DESIGN, SETTING, AND PARTICIPANTS Linked observations across the population-based Surveillance, Epidemiology, and End Results (SEER) program of cancer registries (1975-2013) for 740 990 persons newly diagnosed with cancer from January 2009 through December 2013. Prevalence of prior cancer was estimated by age (<65 years vs >= 65 years) and incident cancer type. MAIN OUTCOMES AND MEASURE'S Prevalence of prior cancer was derived from SEER sequence numbers, which represent the order of all primary reportable tumors diagnosed in a lifetime. Incident cancers were categorized as: (1) first or only primary; (2) second order or higher primary in the same cancer site; and (3) second order or higher primary in a different cancer site. RESULTS Of 765 843 incident cancers diagnosed between 2009 and 2013,141 021(18.4%) represented a second order or higher primary cancer. Overall, approximately one-fourth (25.2%) of older (>= 65 years) and 11% of younger adults newly diagnosed with cancer had a history of prior cancer. Prevalence of prior cancer ranged from 3.5% to 36.9% according to incident cancer type and age, with most prior cancers diagnosed in a different cancer site. CONCLUSIONS AND RELEVANCE A substantial proportion of patients diagnosed with incident cancer in the United States have survived a prior cancer. These patients may be excluded from clinical trials and underrepresented in observational research, and little is known about their treatment and survivorship needs. Understanding the nature and impact of prior cancer is critical to improving clinical trial accrual and generalizability, disease outcomes, and patient experience.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 15 条
[1]   Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States [J].
Bluethmann, Shirley M. ;
Mariotto, Angela B. ;
Rowland, Julia H. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (07) :1029-1036
[2]  
Bradley CJ, 2017, J CLIN ONCOL
[3]   Factors Associated With Use of Preoperative Chemoradiation Therapy for Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium [J].
Charlton, Mary E. ;
Lin, Chi ;
Jiang, Dingfeng ;
Stitzenberg, Karyn B. ;
Halfdanarson, Thorvardur R. ;
Pendergast, Jane F. ;
Chrischilles, Elizabeth A. ;
Wallace, Robert B. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06) :572-579
[4]   Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care [J].
de Moor, Janet S. ;
Mariotto, Angela B. ;
Parry, Carla ;
Alfano, Catherine M. ;
Padgett, Lynne ;
Kent, Erin E. ;
Forsythe, Laura ;
Scoppa, Steve ;
Hachey, Mark ;
Rowland, Julia H. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (04) :561-570
[5]  
Gerber DE, 2015, J COMP EFFECT RES, V4, P289, DOI [10.2217/cer.15.27, 10.2217/CER.15.27]
[6]   Impact of Prior Cancer on Eligibility for Lung Cancer Clinical Trials [J].
Gerber, David E. ;
Laccetti, Andrew L. ;
Xuan, Lei ;
Halm, Ethan A. ;
Pruitt, Sandi L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11)
[7]   Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program [J].
Hayat, Matthew J. ;
Howlader, Nadia ;
Reichman, Marsha E. ;
Edwards, Brenda K. .
ONCOLOGIST, 2007, 12 (01) :20-37
[8]  
Hewitt M., 2005, CANC PATIENT CANC SU
[9]   Quality of Nonmetastatic Colorectal Cancer Care in the Department of Veterans Affairs [J].
Jackson, George L. ;
Melton, L. Douglas ;
Abbott, David H. ;
Zullig, Leah L. ;
Ordin, Diana L. ;
Grambow, Steven C. ;
Hamilton, Natia S. ;
Zafar, S. Yousuf ;
Gellad, Ziad F. ;
Kelley, Michael J. ;
Provenzale, Dawn .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) :3176-3181
[10]  
Johnson C, 2017, 2007 MULTIPLE PRIMAR